Fluorescent iridium(iii) coumarin-salicylaldehyde Schiff base compounds as lysosome-targeted antitumor agents
- 7 April 2020
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 49 (18), 5988-5998
- https://doi.org/10.1039/d0dt00627k
Abstract
Fluorescent iridium(iii) coumarin-salicylaldehyde Schiff base antitumor compounds change the ROS and ΔΨm, induce lysosomal damage, and lead to apoptosis.Keywords
Funding Information
- National Natural Science Foundation of China (21671118)
- Taishan Scholar Project of Shandong Province
This publication has 55 references indexed in Scilit:
- Lysosomes: Signaling Hubs for Metabolic Sensing and LongevityTrends in Cell Biology, 2019
- Cyclometalated iridium(iii) N-heterocyclic carbene complexes as potential mitochondrial anticancer and photodynamic agentsDalton Transactions, 2017
- Dual Detection of Nucleolytic and Proteolytic Markers of Lysosomal Cell Death: DNase II-Type Breaks and Cathepsin DMethods in molecular biology (Clifton, N.J.), 2017
- Lysosomal membrane permeabilization in cell death: new evidence and implications for health and diseaseAnnals of the New York Academy of Sciences, 2015
- Cyclometalated iridium(iii) complexes as lysosome-targeted photodynamic anticancer and real-time tracking agentsChemical Science, 2015
- Anticancer cyclometalated complexes of platinum group metals and goldCoordination Chemistry Reviews, 2013
- Analyzing Lysosomes in Live CellsMethods in Enzymology, 2012
- Lysosome biogenesis and lysosomal membrane proteins: trafficking meets functionNature Reviews Molecular Cell Biology, 2009
- Lysosomes: fusion and functionNature Reviews Molecular Cell Biology, 2007
- Lysosomes in cell deathOncogene, 2004